scholarly article | Q13442814 |
P356 | DOI | 10.1373/49.8.1276 |
P698 | PubMed publication ID | 12881442 |
P50 | author | Lance A. Liotta | Q74243861 |
P2093 | author name string | Emanuel Petricoin | |
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1276-1278 | |
P577 | publication date | 2003-08-01 | |
P1433 | published in | Clinical Chemistry | Q849687 |
P1476 | title | Counterpoint: The vision for a new diagnostic paradigm | |
P478 | volume | 49 |
Q30826870 | A path or a new road in laboratory diagnostics? Biological mass spectrometry: facts and perspectives |
Q36537263 | Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry |
Q48009299 | Analysis of serum proteomic patterns for early cancer diagnosis: drawing attention to potential problems |
Q35850684 | Clinical proteomics: Applications for prostate cancer biomarker discovery and detection |
Q35053674 | Clinical proteomics: present and future prospects. |
Q31060900 | Data processing and classification analysis of proteomic changes: a case study of oil pollution in the mussel, Mytilus edulis |
Q35130542 | Development of gel-filter method for high enrichment of low-molecular weight proteins from serum |
Q33243876 | Surface-enhanced laser desorption/ionization time-of-flight mass spectrometry serum protein profiling to identify nasopharyngeal carcinoma |
Q33289727 | Technology insight: the application of proteomics in gastrointestinal disease |
Q36998685 | The emergence of top-down proteomics in clinical research |
Q36813208 | The road from discovery to clinical diagnostics: lessons learned from the first FDA-cleared in vitro diagnostic multivariate index assay of proteomic biomarkers |
Q24813486 | Ushering in the new toxicology: toxicogenomics and the public interest |
Q33275165 | Validation of SELDI-TOF MS serum protein profiles for renal cell carcinoma in new populations |
Search more.